Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.
J. Neurooncol., Nov (2012)
No scientific support for linking dietary saturated fat to CHD.
Br. J. Nutr., Feb;107(3):455-7; author reply 458-60 (2012)
Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users.
Ann. Thorac. Surg., Jan;93(1):51-7 (2012)
Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.
Neurourol. Urodyn., Nov;30(8):1633-8 (2011)
Assessment of P-glycoprotein activity in the Blood-Brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniques.
Pharm. Res., Oct;28(10):2505-15 (2011)
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance protein.
Bioorg. Med. Chem., Apr;19(7):2190-8 (2011)
Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells.
J. Neurochem., May;117(4):735-46 (2011)
Special requirements of electronic medical record systems in obstetrics and gynecology.
Obstet Gynecol., Oct;116(4):993; author reply 993-4 (2010)
Physicochemical characterization of creatine N-methylguanidinium salts.
J Diet Suppl., Sep;7(3):240-52 (2010)
Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles.
Int J Pharm., Jan;383(1-2):37-44 (2010)
On the mechanism of oleate transport across human brain microvessel endothelial cells.
J. Neurochem., Aug;110(3):1049-57 (2009)
The transition from paper to digital: lessons for medical specialty societies.
AMIA Annu Symp Proc., 475-9 (2008)
Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
Mol. Pharm., 4(5):730-8 (2007 Sep-Oct)
Missing prenatal records at a birth center: a communication problem quantified.
AMIA Annu Symp Proc., 535-9 (2005)
Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.
J. Am. Chem. Soc., May;128(17):5776-85 (2006)
Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Drug Metab. Dispos., Jun;34(6):998-1003 (2006)
Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.
Pharm. Res., Aug;22(8):1259-68 (2005)
Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
Alcohol. Clin. Exp. Res., Jun;29(6):999-1009 (2005)
Using an electronic medical record to improve communication within a prenatal care network.
Obstet Gynecol., Jun;105(6):1488-9; author reply 1489 (2005)
Effect of particle size of nanospheres and microspheres on the cellular-association and cytotoxicity of paclitaxel in 4T1 cells.
Pharm. Res., May;22(5):766-75 (2005)
A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier.
Pharm. Res., Jan;22(1):113-21 (2005)
Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier.
Pharm. Res., Nov;21(11):1993-2000 (2004)
Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells.
J. Pharmacol. Exp. Ther., Nov;311(2):449-55 (2004)
Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF.
J Pharm Sci., Apr;93(4):932-42 (2004)
Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.
Pharm. Res., Oct;20(10):1581-90 (2003)
A systematic approach to endodontic diagnosis.
J Dist Columbia Dent Soc., 9-10 (1976)